The execution gap

Name: Implement Consulting Group
Price range: $

How the U.S. life sciences industry is winning the science race and losing the transformation battle

Published

25 August 2026

_FOREWORD

A unique time for the U.S. life sciences industry

The U.S. life sciences industry is having its best decade and its hardest one at the same time. Recently, a gap has been emerging for multiple clients between where an organization intends to go and its actual capacity to get there.

This disconnect is seen through manufacturing capacity that has potential but an unknown workforce plan. The commercial launch ambition is clear, but the operational readiness is not. A company’s 2030 vision is sharp, while the 90-day execution plan is vague. Persistent operational gaps between where an organization wants to go and what it can realistically execute are beginning to take hold of a longstanding industry built on rigor, compliance, and regulation.

The organizations we work with are not short on intelligence, ambition, or capital. The organizational infrastructure required to match the pace of these systemic changes is outdated and outpaced, creating pain points that must be addressed and built into organizational strategy. Leadership pipelines, middle management layers, and planning cycles must adapt to the slew of change with more clarity by closing the gap between ambition and execution.

The organizations that address and close that gap first can define what U.S. life sciences looks like for the next decade.

Get the full whitepaper

Download the full whitepaper on how the U.S. life sciences industry is winning the science race and losing the transformation battle.

_{EXECUTIVE SUMMARY}

The execution gap and current moment

There is a paradox at the center of U.S. life sciences in 2026.

Revenues are at historic highs. Capital investment in U.S. manufacturing is accelerating. Breakthrough therapeutic pipelines, including GLP-1 therapies and advanced genetic modalities, are reshaping disease treatment and bringing research into reality. By every external measure, the industry is strong and growing.

However, organizational leaders describe a different reality, often feeling stretched, strained, and under pressure to execute effectively amid rapid and sustained change. We refer to this disparity as the execution gap: the accumulated distance between where an organization wants to go and its actual operational, organizational, and human capacity to get there.

Our central argument is that this gap emerges when strategic ambition and capital investment move faster than the organizational infrastructure required to translate them into coordinated decisions, workforce capability, and operational readiness.

Three forces are now exposing and intensifying this gap: a manufacturing renaissance building capacity faster than the capability to use it, a therapeutic modality shift demanding commercial and operational readiness that many organizations do not yet have, and an AI deployment wave that is too often used to reduce headcount rather than build capability. None of these forces created the execution gap. Rather, they exposed it.

The execution gap has been accumulating for years. What the current moment has done is make the cost of leaving it unaddressed too high to defer. This paper examines where the execution gap comes from and what leaders can do to close it.